JUBILANT PHARMOVA LTD Intrinsic Value
JUBLPHARMA · Healthcare · Current price ₹1,022.6
Is JUBILANT PHARMOVA LTD undervalued?
DocStoX estimates the fair value of JUBILANT PHARMOVA LTD at ₹583 per share, versus the current market price of ₹1,023. That puts the stock about -43.0% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹411), Relative P/E (₹973), Graham floor (₹501). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹411 (bear) to ₹583 (base) to ₹973 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,023 versus an intrinsic value of ₹583, JUBILANT PHARMOVA LTD currently offers -43.0% of negative margin (i.e. a premium).
More on JUBILANT PHARMOVA LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.